APA (7th ed.) Citation

De Kam, P., Kruithof, A. C., van Lierop, M., Moerland, M., Dennie, J., Troyer, M. D., . . . El Galta, R. (2014). Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects. International journal of clinical pharmacology and therapeutics, 52(8), 631. https://doi.org/10.5414/CP202091

Chicago Style (17th ed.) Citation

De Kam, Pieter-Jan, et al. "Lack of a Clinically Relevant Effect of Sugammadex on Anti-Xa Activity or Activated Partial Thromboplastin Time Following Pretreatment with Either Unfractionated or Low-molecular-weight Heparin in Healthy Subjects." International Journal of Clinical Pharmacology and Therapeutics 52, no. 8 (2014): 631. https://doi.org/10.5414/CP202091.

MLA (9th ed.) Citation

De Kam, Pieter-Jan, et al. "Lack of a Clinically Relevant Effect of Sugammadex on Anti-Xa Activity or Activated Partial Thromboplastin Time Following Pretreatment with Either Unfractionated or Low-molecular-weight Heparin in Healthy Subjects." International Journal of Clinical Pharmacology and Therapeutics, vol. 52, no. 8, 2014, p. 631, https://doi.org/10.5414/CP202091.